Literature DB >> 6608952

Complement activation during cardiopulmonary bypass by heparin-protamine interaction.

N Best, M J Sinosich, B Teisner, J G Grudzinskas, M M Fisher.   

Abstract

Circulating concentrations of split products of the third complement factor (C3c and C3d) were measured in five patients before, during and after cardiopulmonary bypass. In all patients, C3d concentrations increased significantly in samples obtained after the administration of protamine sulphate. Similarly, circulating C3c was seen only in those samples obtained immediately after protamine administration. In vitro experiments demonstrated that activation of the complement system was attributable to the heparin-protamine complex, and was dose-dependent. The activation of complement was not associated with any clinically detectable adverse effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6608952     DOI: 10.1093/bja/56.4.339

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  4 in total

1.  Complement activation during cardiac and thoracic vascular operations.

Authors:  P G Loubser
Journal:  Tex Heart Inst J       Date:  1987-12

2.  Ketanserin in the treatment of protamine-induced pulmonary hypertension.

Authors:  P J van der Starre; C Solinas
Journal:  Tex Heart Inst J       Date:  1996

Review 3.  Allergy to protamine.

Authors:  M E Weiss; N F Adkinson
Journal:  Clin Rev Allergy       Date:  1991 Fall-Winter

4.  Value of C-reactive protein in reflecting the magnitude of complement activation in children undergoing open heart surgery.

Authors:  M Aronen; M Leijala; S Meri
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.